Clozapine, Long-Acting Injectables (and Polypharmacy?) Superior in US and International Registries

被引：5
|
作者：
Leucht, Stefan [1 ]
Tiihonen, Jari [2 ,3 ]
机构：
[1] Tech Univ Munich, Sch Med, Dept Psychiat & Psychotherapy, Munich, Germany
[2] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden
[3] Univ Eastern Finland, Dept Forens Psychiat, Kuopio, Finland
来源：
AMERICAN JOURNAL OF PSYCHIATRY | 2021年 / 178卷 / 10期
关键词：
NATIONWIDE COHORT; SCHIZOPHRENIA; METAANALYSIS;
D O I：
10.1176/appi.ajp.2021.21080825
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：888 / 889
页数：2
相关论文
共 50 条
  • [41] Systematic review of long-acting injectables versus oral atypical antipsychotics on hospitalization in schizophrenia
    Lafeuille, Marie-Helene
    Dean, Jason
    Carter, Valerie
    Duh, Mei Sheng
    Fastenau, John
    Dirani, Riad
    Lefebvre, Patrick
    CURRENT MEDICAL RESEARCH AND OPINION, 2014, 30 (08) : 1643 - 1655
  • [42] REAL-WORLD UTILISATION AND TREATMENT PATTERNS OF ATYPICAL LONG-ACTING INJECTABLES IN AUSTRALIA
    Pai, N.
    Puig, A.
    Brahmbhat, P.
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2022, 56 (1_SUPPL): : 245 - 245
  • [43] Use of Long-Acting Injectables in Borderline Personality Disorder: What Do We Know?
    Almeida, E. D. S.
    Abreu, J.
    Vaz, R. P.
    Martins, J.
    Cunha, F.
    Santos, I.
    Castro, N.
    Andrade, R. P.
    Monteiro, E.
    EUROPEAN PSYCHIATRY, 2024, 67 : S119 - S119
  • [44] The modern perspective for long-acting injectables antipsychotics in the patient-centered care of schizophrenia
    Pietrini, Francesco
    Albert, Umberto
    Ballerini, Andrea
    Calo, Paola
    Maina, Giuseppe
    Pinna, Federica
    Vaggi, Marco
    Boggian, Ileana
    Fontana, Maria
    Moro, Cesare
    Carpiniello, Bernardo
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2019, 15 : 1045 - 1060
  • [45] The AAPS Journal Theme Issue: “Perspectives on Clinical Drug Development of Long-Acting Injectables”
    Huybrecht T’jollyn
    Oliver Ackaert
    The AAPS Journal, 25
  • [46] Long-acting antipsychotic injectables in patients under compulsory outpatient treatment: the right to choose
    Pinto, C. Mota
    Klut, C.
    Heitor, M. J.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2021, 53 : S389 - S389
  • [47] OPTIMIZING TREATMENT OF SCHIZOPHRENIA: PHARMACOECONOMIC CONSEQUENCES AND POTENTIAL FOR PATIENT SWITCHING TO LONG-ACTING INJECTABLES
    Zaniolo, O.
    Pradelli, L.
    Franchi, A.
    Maffezzoli, S.
    VALUE IN HEALTH, 2023, 26 (12) : S146 - S146
  • [48] The AAPS Journal Theme Issue: "Perspectives on Clinical Drug Development of Long-Acting Injectables"
    T'jollyn, Huybrecht
    Ackaert, Oliver
    AAPS JOURNAL, 2023, 25 (06):
  • [49] Partial AUCs in Long-Acting Injectables: Rationale, Challenges, Variability, Usefulness, and Clinical Relevance
    Tsakiridou, Georgia
    Angelerou, Maria-Faidra-Galini
    Efentakis, Panagiotis
    Margaritis, Antonios
    Papanastasiou, Antigoni-Maria
    Kalantzi, Lida
    PHARMACEUTICS, 2025, 17 (01)
  • [50] Utilizing long-acting injectables to address noncompliance among adolescents diagnosed with bipolar disorder
    Sood, Kanuja
    Buddhavarapu, Mahiya
    Bansal, Lajpat Rai
    Schaefer, Daniel
    Parikh, Parinda
    BIPOLAR DISORDERS, 2024, 26 (08) : 831 - 834
12345